DeepCT vs Rapid SDH

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Deep01 Limited
VS
by RapidAI (formerly iSchemaView)

AI Verdict

DeepCT offers a broader range of detection for various brain abnormalities, including intracranial hemorrhage (ICH), acute stroke, traumatic brain injury (TBI), and fractures. Rapid SDH specializes in the rapid detection of acute and chronic subdural hematomas (a type of ICH), positioning itself as a focused module within a comprehensive hemorrhagic and trauma care AI solution. Therefore, DeepCT might be preferred for a wider array of brain pathologies, while Rapid SDH is highly specialized for subdural hematoma detection.

Choose DeepCT if…

Choose DeepCT if your facility requires a comprehensive AI solution for the rapid detection and triage of a wide range of brain abnormalities from non-contrast CT scans. This tool is ideal for emergency departments needing to prioritize worklists and identify not only intracranial hemorrhage but also midline shifts, acute strokes, traumatic brain injury, and fractures, offering broader diagnostic support.

View DeepCT →

Choose Rapid SDH if…

Choose Rapid SDH if your primary need is highly specialized and rapid detection of suspected acute and chronic subdural hematomas. This module excels in delivering near real-time notifications specifically for SDH, making it crucial for neurocritical care teams focused on expediting decisions for this particular condition with high accuracy.

View Rapid SDH →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DeepCT Rapid SDH
Pricing Contact for details Contact vendor
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Integration in standard reading environment (PACS), Stand-alone third party application, Stand-alone web-based Cloud-based, On-premise
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DeepCT Rapid SDH
Name DeepCT Rapid SDH
Company Deep01 Limited RapidAI (formerly iSchemaView)
Primary Detection Focus Intracranial hemorrhage (ICH) and other brain abnormalities Acute and chronic subdural hematomas (SDH)
Key Features (beyond primary detection) Notification to clinicians for suspected findings, Segmentation and quantification of ICH, Worklist prioritization for time-sensitive cases, Detection of midline shift, Detection of acute stroke, Detection of traumatic brain injury (TBI), Detection of fractures Notifications to clinicians in one minute or less, High positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml, Integration with Rapid mobile app, PACS, and email for notifications, Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity), Analyzes non-contrast CT scans, Aids in streamlining decision-making and expediting patient care, Supports identification of treatment eligibility

Videos

Demos, reviews, and walkthroughs featuring DeepCT and Rapid SDH.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DeepCT is designed for the rapid detection and triage of suspected intracranial hemorrhage (ICH) and other brain abnormalities, including midline shift, acute stroke, traumatic brain injury (TBI), and fractures. Rapid SDH, on the other hand, specifically focuses on the rapid detection of suspected acute and chronic subdural hematomas (SDH).
DeepCT provides notifications to clinicians for suspected findings and offers worklist prioritization for time-sensitive cases. It can integrate into standard reading environments like PACS. Rapid SDH delivers notifications to clinicians in one minute or less, integrating with the Rapid mobile app, PACS, and email for alerts.
DeepCT includes features for the segmentation and quantification of intracranial hemorrhage (ICH). The provided information for Rapid SDH focuses on detection and notification, without explicitly mentioning quantification features.
Rapid SDH reports a high positive predictive value (PPV) of 99%, with 93% sensitivity and 99% specificity for subdural hematomas (SDHs) greater than 1ml. The provided information for DeepCT does not include specific performance metrics such as sensitivity or specificity.
Rapid SDH is explicitly stated to be part of a comprehensive hemorrhagic and trauma care AI solution, which includes Rapid ICH and Rapid Hyperdensity. DeepCT is described as an FDA-cleared AI software for detection and triage of various brain abnormalities.
AI Tool Finder
AI-powered search. Results may not be comprehensive.